Skip to main content
Log in

CNS-related side-effects with metoprolol and atenolol

  • β-Blockers And CNS Side-Effects
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Vivid and bizarre dreams, hallucinations, sleep disturbance and psychosis have all been described following treatment with β-Blockers. It has been suggested that these central nervous system (CNS) side-effects are related to the degree of lipophilicity of the β-blocker. A randomized double-blind crossover study was performed to compare the incidence of CNS side-effects with atenolol and metoprolol in hypertensive patients who had reported CNS side-effects with lipophilic β-Blockers. Eleven women and six men completed the study, in which a 30-item psychiatric questionnaire was used to detect changes in psychological status and possible CNS side-effects. Discontinuation of the original lipophilic β-blocker produced a significant improvement in quality of sleep, dreams, concentration, memory, energy, and anxiety. No significant CNS side-effects were reported with atenolol, but introduction of metoprolol caused a significant increase in the incidence of sleep disturbance (p<0.01) and restless nights (p<0.05), as well as failure to achieve satisfactory sexual intercourse (p<0.05). When compared with atenolol, metoprolol was associated with a significantly higher incidence of restless disturbed nights (p<0.05). Blood pressure control was identical for both β-Blockers. This study appears to confirm the association between CNS-related side-effects and the lipophilicity of β-Blockers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Betts TA, Alford C (1983) Beta-blocking drugs and sleep: a controlled trial. Drugs 25 (Suppl 2): 268–272

    Google Scholar 

  2. Cruickshank JM (1980) The clinical importance of cardiose-lectivity and lipophilicity in beta-blockers. Am Heart J 100: 160–178

    Google Scholar 

  3. Fleminger R (1978) Visual hallucinations and illusions with propranolol. Br Med J 1: 1182

    Google Scholar 

  4. Fraser HS, Carr AC (1976) Propranolol psychosis. Br J Psychiatry 129: 508–509

    Google Scholar 

  5. Lennard MS, Silas JH, Freestone S, Trevethick J (1982) Defective metabolism of metoprolol in poor hydroxylators of debrisoquine. Br J Clin Pharmacol 14: 301–303

    Google Scholar 

  6. Mattiasson I, Henningsen NC (1978) Side-effects during treatment with lipid-soluble beta-adrenergic-blocking substances. Abstract. Proceedings of VIII World Congress of Cardiology, Tokyo: 367

  7. Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM (1981) Beta-adrenoceptor blockers and the blood-brain barrier. Br J Clin Pharmacol 11: 549–553

    Google Scholar 

  8. Simpson WT (1977) Nature and incidence of unwanted effects with atenolol. Postgrad Med J 53 (Suppl 3): 162–167

    Google Scholar 

  9. Westerlund A (1983) A comparison of the central nervous system side effects caused by lipophilic and hydrophilic beta-blockers. Drugs 25 (Suppl 2): 280–281

    Google Scholar 

  10. Woods PB, Robinson ML (1981) An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. J Pharm Pharmacol 33: 172–173

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cove-Smith, J.R., Kirk, C.A. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 28 (Suppl 1), 69–72 (1985). https://doi.org/10.1007/BF00543713

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543713

Key words

Navigation